<DOC>
	<DOCNO>NCT00400335</DOCNO>
	<brief_summary>The combination testosterone dutasteride intend use hypogonadal men . This study evaluate bioavailability pharmacokinetics various dos testosterone administer without dutasteride</brief_summary>
	<brief_title>Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Eunuchism</mesh_term>
	<mesh_term>Dutasteride</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Inclusion criterion : Are healthy . Have BMI within range 1932 kg/m2 . Have take dutasteride one year , finasteride past 3 month . Have screen PSA &lt; 2.0ng/mL . Exclusion criterion : Have breast prostate cancer , sleep apnea , psychiatric illness , clinically significant current condition . Have trigliceride level =500mg/dL . Have abnormal thyroid hormone level . Would donate 500 ML blood 2 month period . Physician think good idea participate trial . Are unwilling abstain alcohol study . Have positive urine drug screen test . Plan change smoke habit course trial . Have Hepatitis C , Hepatitis B , HIV . Have lab ECG abnormality . Have high low blood pressure . Have use investigational drug device study within 30 day prior 1st dose study medication .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Testosterone</keyword>
	<keyword>Men</keyword>
	<keyword>Hypogonadism</keyword>
	<keyword>Dutasteride</keyword>
	<keyword>DHT</keyword>
	<keyword>Androgen deficiency</keyword>
</DOC>